These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30448829)

  • 1. Impact of Locoregional Treatment on Prognosis of de novo Stage IV Breast Cancer: A Retrospective Long-Term Study of Chinese Population.
    Wang W; Liu J; Wang J; Gao J; Wang X; Wang X
    Gynecol Obstet Invest; 2019; 84(3):248-258. PubMed ID: 30448829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of postoperative radiotherapy after primary tumor resection in patients with de novo stage IV breast cancer.
    Kim YJ; Kim SS; Ahn SD; Jung J; Ahn SH; Son BH; Lee JW; Kim HJ; Ko BS; Kim SB; Jung KH; Ahn JH; Kim JE; Choi EK
    Asia Pac J Clin Oncol; 2021 Dec; 17(6):495-505. PubMed ID: 33179406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis?
    Nguyen DH; Truong PT; Alexander C; Walter CV; Hayashi E; Christie J; Lesperance M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):39-45. PubMed ID: 22330986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
    Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
    Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer.
    Akay CL; Ueno NT; Chisholm GB; Hortobagyi GN; Woodward WA; Alvarez RH; Bedrosian I; Kuerer HM; Hunt KK; Huo L; Babiera GV
    Cancer; 2014 May; 120(9):1319-28. PubMed ID: 24510381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
    Kommalapati A; Tella SH; Goyal G; Ganti AK; Krishnamurthy J; Tandra PK
    Breast Cancer Res Treat; 2018 Aug; 170(3):677-685. PubMed ID: 29721715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study.
    Tan Y; Li X; Chen H; Hu Y; Jiang M; Fu J; Yuan Y; Ding K
    Oncotarget; 2016 Oct; 7(43):70991-71000. PubMed ID: 27542240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life.
    Si Y; Yuan P; Hu N; Wang X; Ju J; Wang J; Ma F; Luo Y; Zhang P; Li Q; Xu B
    Ann Surg Oncol; 2020 Apr; 27(4):1025-1033. PubMed ID: 31970572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
    Babiera GV; Rao R; Feng L; Meric-Bernstam F; Kuerer HM; Singletary SE; Hunt KK; Ross MI; Gwyn KM; Feig BW; Ames FC; Hortobagyi GN
    Ann Surg Oncol; 2006 Jun; 13(6):776-82. PubMed ID: 16614878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China.
    Ma L; Mi Y; Cui S; Wang H; Fu P; Yin Y; Jin F; Li J; Liu Y; Fan Z; Zhang H; Geng C; Jiang Z
    Sci Rep; 2020 Oct; 10(1):18132. PubMed ID: 33093581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis.
    van der Hage JA; Putter H; Bonnema J; Bartelink H; Therasse P; van de Velde CJ;
    Eur J Cancer; 2003 Oct; 39(15):2192-9. PubMed ID: 14522378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast conservative therapy in Pakistani women: Prognostic factors for locoregional recurrence and overall survival.
    Bhatti AB; Jamshed A; Shah MA; Khan A
    J Cancer Res Ther; 2015; 11(2):300-4. PubMed ID: 26148589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Locoregional surgery for stage IV breast cancer patients].
    Lotersztajn N; Héquet D; Mosbah R; Rouzier R
    Gynecol Obstet Fertil; 2015 Apr; 43(4):304-8. PubMed ID: 25819388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
    Chen W; Huang Y; Lewis GD; Szeja SS; Hatch SS; Farach A; Miltenburg D; Butler EB; Chang JC; Teh BS
    Clin Breast Cancer; 2018 Feb; 18(1):e97-e105. PubMed ID: 28888581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.
    Fitzal F; Bjelic-Radisic V; Knauer M; Steger G; Hubalek M; Balic M; Singer C; Bartsch R; Schrenk P; Soelkner L; Greil R; Gnant M;
    Ann Surg; 2019 Jun; 269(6):1163-1169. PubMed ID: 31082916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.